CN101596267A - A kind of Chinese medicine composition for the treatment of intestinal tract disease and its production and application - Google Patents

A kind of Chinese medicine composition for the treatment of intestinal tract disease and its production and application Download PDF

Info

Publication number
CN101596267A
CN101596267A CNA200910158382XA CN200910158382A CN101596267A CN 101596267 A CN101596267 A CN 101596267A CN A200910158382X A CNA200910158382X A CN A200910158382XA CN 200910158382 A CN200910158382 A CN 200910158382A CN 101596267 A CN101596267 A CN 101596267A
Authority
CN
China
Prior art keywords
herba
chinese medicine
rhizoma
intestinal tract
tract disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA200910158382XA
Other languages
Chinese (zh)
Other versions
CN101596267B (en
Inventor
李文良
王淑英
王强
刘元生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200910158382XA priority Critical patent/CN101596267B/en
Publication of CN101596267A publication Critical patent/CN101596267A/en
Application granted granted Critical
Publication of CN101596267B publication Critical patent/CN101596267B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of Chinese medicine composition for the treatment of intestinal tract disease and its production and application, be the medicament of making by the raw material of following weight portion: wild Flos persicae 25-45, Radix Scutellariae 25-45, Folium Isatidis 25-45, Cortex Phellodendri 25-45, Fructus Trichosanthis 15-35, Herba Taraxaci 35-55, Rhizoma Bistortae 25-45, Rhizoma Paridis 25-45, Rhizoma Chuanxiong 15-35, Stigma Croci 5-20 hides Ganoderma 25-45, Cordyceps 1-5, Ramulus et folium taxi cuspidatae 25-45, Radix Et Rhizoma Rhei 15-35, Herba Patriniae 15-35, Cortex Moutan 15-35, Herba Violae 15-35, Herba Hedyotidis Diffusae 25-45, Caulis Sargentodoxae 25-45.Through inventor's more than 10 year clinical confirmation can blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, damp-clearing pain-relieving, enhancing autoimmune function, can be anticancer, kill tumor and cancerous cell.Confirmed to control intestinal obstruction effective percentage 100% by more than 10 years clinical, controlled that enterodynia is swollen, intestinal neoplasms, malignant tumor effective percentage 98%.

Description

A kind of Chinese medicine composition for the treatment of intestinal tract disease and its production and application
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of intestinal tract disease and its production and application, more particularly relating to a kind of is the Chinese medicine composition and its production and application of raw material treatment intestinal tract disease with Chinese medicine.
Background technology
The traditional Chinese medical science thinks that it is one of main etiology and pathology of malignant tumor that pyretic toxicity pents up.The effect of method of dissipating heat and detoxifying treatment existing direct inhibition of tumor or killing tumor cell can improve body's immunological function again and reaches therapeutic effect, is stranded this, and method of dissipating heat and detoxifying utilization in the treatment malignant tumor is more.Often will intimately be divided into two classes clinically, i.e. burning hot the and interior life of diseases caused by exogenous pathogenic factor be heat.No matter be the burning hot heresy of diseases caused by exogenous pathogenic factor or other all evil human bodies of invading, give birth to burning hot in can both being converted into.Simultaneously, internal injury caused by excess of seven emotions and visceral dysfunction, also heat-transformation is lit a fire in vivo.Be YANG pathogen, its property is burnt bright, and the easiest impairment of body fluid consumption gas is given birth to pneumatic blood and the cloudy deteriorated blood that burns.Accumulate in the body in the burning hot heresy, the visitor is in flesh and blood, and harmony is poly-does not loose, and the corrosion flesh and blood all can lead to pus of carbuncle, or sends out and be tumor.Excess-fire has significantly burning hot flourishing symptom, and it is not obvious that the moon is hindered symptom, as hyperpyrexia, and thirst and desire for cold drink, the appearance knot is red, and it is red etc. that constipation is urinated; Asthenic fire then based on the moon wound, has deficiency-heat syndrome, as afternoon low grade fever, and dysphoria with feverish sensation in the chest palms and soles, night sweat, dry pharynx, the tip of the tongue is light red etc.Intimately go into blood system, can stagnate in the part, the corrosion flesh and blood is sent out and is the carbuncle skin infection.Penting up the mechanism that causes carcinoma about pyretic toxicity also has a lot of documents to set forth.Clinically see that the carcinoma patient is the disease of heat stagnation fire-toxin more, no matter excess-fire (heat), asthenic fire (heat), all calorific potential sparrow hawks open, and illustrates that tumor develops, and belong to resembling that disease advances, and this moment is at pathogenesis, to the method for this carcinoid tumor patient when plan heat-clearing and toxic substances removing, nourishing YIN to lower pathogenic fire.As many diseases body void of a specified duration, stasis of blood poison caves in, and the state of an illness is turned out cloudy by sun, becomes insidious heresy, then forms the erosion of vulva and dislikes cellulitis, and magic flower festers, granuloma, seepage flow blood and slime.Control insidious heresy, then need the temperature compensation Tuoli, strengthening vital QI to eliminate pathogenic factors is dispeled insidious heresy with QI and blood regulating.
Summary of the invention
One of purpose of the present invention provides that a kind of treatment intestinal tract disease, particularly enterodynia are swollen, the intestinal stalk is stifled, the Chinese medicine composition of intestinal neoplasms and malignant tumor.
Two of purpose of the present invention provides that a kind of treatment intestinal tract disease, particularly enterodynia are swollen, the intestinal stalk is stifled, the preparation method of the Chinese medicine composition of intestinal neoplasms and malignant tumor.
These and other purpose of the present invention will further embody and set forth by following detailed description and explanation.
The Chinese medicine composition of treatment intestinal tract disease of the present invention is the medicament of being made by the raw material of following weight portion:
Wild Flos persicae 25-45 Radix Scutellariae 25-45 Folium Isatidis 25-45
Cortex Phellodendri 25-45 Fructus Trichosanthis 15-35 Herba Taraxaci 35-55
Rhizoma Bistortae 25-45 Rhizoma Paridis 25-45 Rhizoma Chuanxiong 15-35
Stigma Croci 5-20 hides Ganoderma 25-45 Cordyceps 1-5
Ramulus et folium taxi cuspidatae 25-45 Radix Et Rhizoma Rhei 15-35 Herba Patriniae 15-35
Cortex Moutan 15-35 Herba Violae 15-35 Herba Hedyotidis Diffusae 25-45
Caulis Sargentodoxae 25-45.
Further, the Chinese medicine composition of treatment intestinal tract disease of the present invention is the medicament of being made by the raw material of following weight portion:
Wild Flos persicae 30-40 Radix Scutellariae 30-40 Folium Isatidis 30-40
Cortex Phellodendri 30-40 Fructus Trichosanthis 20-30 Herba Taraxaci 40-50
Rhizoma Bistortae 30-40 Rhizoma Paridis 30-40 Rhizoma Chuanxiong 20-30
Stigma Croci 10-20 hides Ganoderma 30-40 Cordyceps 2-4
Ramulus et folium taxi cuspidatae 30-40 Radix Et Rhizoma Rhei 20-30 Herba Patriniae 20-30
Cortex Moutan 20-30 Herba Violae 20-30 Herba Hedyotidis Diffusae 30-40
Caulis Sargentodoxae 30-40.
What can select is that the Chinese medicine composition of treatment intestinal tract disease of the present invention is the medicament of being made by the raw material of following weight portion:
Wild Flos persicae 30-35 Radix Scutellariae 30-35 Folium Isatidis 30-35
Cortex Phellodendri 30-35 Fructus Trichosanthis 25-30 Herba Taraxaci 45-50
Rhizoma Bistortae 30-35 Rhizoma Paridis 30-35 Rhizoma Chuanxiong 25-30
Stigma Croci 10-15 hides Ganoderma 30-35 Cordyceps 2-4
Ramulus et folium taxi cuspidatae 30-35 Radix Et Rhizoma Rhei 25-30 Herba Patriniae 25-30
Cortex Moutan 25-30 Herba Violae 25-30 Herba Hedyotidis Diffusae 30-35
Caulis Sargentodoxae 30-35.
Be preferably, the Chinese medicine composition of treatment intestinal tract disease of the present invention is the medicament of being made by the raw material of following weight portion:
Wild Flos persicae 35 Radix Scutellariaes 35 Folium Isatidiss 35
Cortex Phellodendri 35 Fructus Trichosanthis 25 Herba Taraxacis 45
Rhizoma Bistortae 35 Rhizoma Paridis 35 Rhizoma Chuanxiongs 25
Stigma Croci 15 is hidden Ganoderma 35 Cordyceps 3
Ramulus et folium taxi cuspidatae 35 Radix Et Rhizoma Rhei 25 Herba Patriniae 25
Cortex Moutan 25 Herba Violaes 25 Herba Hedyotidis Diffusaes 35
Caulis Sargentodoxae 35.
In the Chinese medicine composition of treatment intestinal tract disease of the present invention, described medicament is the above a dosage form of any pharmaceutics, and dosage form is an oral liquid preferably.Described intestinal tract disease is that enterodynia is swollen, the intestinal stalk is stifled, intestinal neoplasms and malignant tumor.
The preparation method of the Chinese medicine composition of treatment intestinal tract disease of the present invention is through flushing with clean water, section and pulverizing with above-mentioned Chinese medicine, put into extraction pot then, by solid-to-liquid ratio 1: 5-15 puts into water, through 100 ℃ of steaming and decocting 1.5-3 hours, filter, get and filter the back liquid cools and sealed in 24 hours.
Further, the preparation method of the Chinese medicine composition of treatment intestinal tract disease of the present invention is through flushing with clean water, section and pulverizing with above-mentioned Chinese medicine, put into extraction pot then, by solid-to-liquid ratio 1: 8-10 puts into water, through 100 ℃ of steaming and decocting 1.5-2 hours, filter, get and filter the back liquid cools and sealed in 24 hours.
What can select is, the preparation method of the Chinese medicine composition of treatment intestinal tract disease of the present invention be with above-mentioned Chinese medicine through flushing with clean water, section and pulverizing, put into extraction pot then, by solid-to-liquid ratio 1: 5-10 puts into water, through 100 ℃ of steaming and decocting 1.5-2 hours, filtration, win time filtrate extracts once more, and by solid-to-liquid ratio 1: 3-5 puts into water, through 100 ℃ of steaming and decocting 0.5-1 hours, filtration, filtrate for the second time, merge secondary filter liquid, cool off and sealed in 24 hours.
In the present invention, the performance of each medicine is: Flos persicae: belong to five wood elite, can wide intestinal, pain disappears; Rhizoma Chuanxiong: invigorate blood circulation, blood stasis dispelling; Flos Carthami: invigorate blood circulation, blood stasis dispelling; Cortex Moutan: heat-clearing and toxic substances removing, removing heat from blood, detumescence, dissipating blood stasis; Herba Violae: heat-clearing and toxic substances removing, removing heat from blood, detumescence, dissipating blood stasis; Caulis Sargentodoxae, Herba Hedyotidis Diffusae: heat-clearing and toxic substances removing, pain, eliminating stagnation, blood stasis dispelling, pain relieving disappear; Herba Patriniae, Folium Isatidis: heat-clearing and toxic substances removing, pain, eliminating stagnation, blood stasis dispelling, pain relieving disappear; Rhizoma Bistortae, Rhizoma Paridis: heat-clearing and toxic substances removing, pain, eliminating stagnation, blood stasis dispelling, pain relieving disappear; Herba Taraxaci: heat-clearing and toxic substances removing, pain, eliminating stagnation, blood stasis dispelling, pain relieving disappear; Radix Et Rhizoma Rhei: heat and toxic materials clearing away, clearing away heat-fire, detoxifcation, blood circulation promoting and blood stasis dispelling; Cortex Phellodendri: clearing away heat-fire, detoxifcation, remove part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels damp-edema; Radix Scutellariae, Fructus Trichosanthis: heat-clearing and toxic substances removing, conditioning pulmonary, large intestine and lung mutually the exterior and the interior, can reconcile the wriggling function of large intestine; Hide Ganoderma, Cordyceps, Ramulus et folium taxi cuspidatae: the immunologic function that can strengthen self can be anticancer.More than the combination of these medicines, through the clinical confirmation in more than 10 year of inventor can blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, damp-clearing pain-relieving, enhancing autoimmune function, can be anticancer, kill tumor and cancerous cell.Confirmed to control the stifled effective percentage 100% of intestinal stalk by more than 10 years clinical, controlled that enterodynia is swollen, intestinal neoplasms, malignant tumor effective percentage 98%.
Instructions of taking:
Treat constipation: each was obeyed the 60-80 milliliter once, at every turn, just led to decrement sooner or later every day, obeyed 3 days again.
It is stifled to control the intestinal stalk: every day 3 times, each 80-100 milliliter; Severe patient: by 6 hours clothes once, just logical back decrement was obeyed 3 days again.
Control that enterodynia is swollen, intestinal neoplasms, malignant tumor: by 1 medicine of 6 hours clothes, obey the 100-110 milliliter at every turn; Severe patient: oral medicine adds medicine coloclysis, coloclysis once a day, each 120-350 milliliter.
Points for attention: Flos persicae people hypersensitive, can not take.
Below further specify the present invention by specific embodiment, but embodiment only be used for the explanation, can not limit the scope of the invention.
In the present invention, if not refer in particular to, all parts, amount, percentage ratio are unit of weight, and all raw materials all can be buied from market.
Four, the specific embodiment
Embodiment 1
Take by weighing raw material by following proportioning:
Wild Flos persicae 35 gram Radix Scutellariaes 35 gram Folium Isatidiss 35 gram Cortex Phellodendris 35 grams
Fructus Trichosanthis 25 gram Herba Taraxacis 45 gram Rhizoma Bistortaes the 35th grammes per square metre buildings 35 grams
Rhizoma Chuanxiong 25 gram Stigma Crocis 15 grams are hidden Ganoderma 35 gram Cordyceps 3 grams
Ramulus et folium taxi cuspidatae 35 gram Radix Et Rhizoma Rhei 25 gram Herba Patriniae 25 gram Cortex Moutans 25 grams
Herba Violae 25 gram Herba Hedyotidis Diffusaes 35 gram Caulis Sargentodoxaes 35 grams.
Above-mentioned Chinese medicine through flushing with clean water, section and pulverizing, is put into extraction pot then, and by solid-to-liquid ratio 1: 8-10 puts into water, through 100 ℃ of steaming and decocting 1.5-2 hours, filter, get and filter the back liquid cools and sealed in 24 hours.
Embodiment 2
Take by weighing raw material by following proportioning:
Wild Flos persicae 45 gram Radix Scutellariaes 45 gram Folium Isatidiss 45 gram Cortex Phellodendris 45 grams
Fructus Trichosanthis 35 gram Herba Taraxacis 55 gram Rhizoma Bistortaes the 45th grammes per square metre buildings 45 grams
Rhizoma Chuanxiong 35 gram Stigma Crocis 20 grams are hidden Ganoderma 45 gram Cordyceps 4 grams
Ramulus et folium taxi cuspidatae 45 gram Radix Et Rhizoma Rhei 35 gram Herba Patriniae 35 gram Cortex Moutans 35 grams
Herba Violae 35 gram Herba Hedyotidis Diffusaes 45 gram Caulis Sargentodoxaes 45 grams.
Above-mentioned Chinese medicine through flushing with clean water, section and pulverizing, is put into extraction pot then, put into water at 1: 9, through 100 ℃ of steaming and decoctings 1.5 hours, filter, get and filter the back liquid cools and sealed in 24 hours by solid-to-liquid ratio.
Embodiment 3
Take by weighing raw material by following proportioning:
Wild Flos persicae 25 gram Radix Scutellariaes 25 gram Folium Isatidiss 25 gram Cortex Phellodendris 25 grams
Fructus Trichosanthis 25 gram Herba Taraxacis 35 gram Rhizoma Bistortaes the 25th grammes per square metre buildings 25 grams
Rhizoma Chuanxiong 25 gram Stigma Crocis 5 grams are hidden Ganoderma 25 gram Cordyceps 1 gram
Ramulus et folium taxi cuspidatae 25 gram Radix Et Rhizoma Rhei 15 gram Herba Patriniae 15 gram Cortex Moutans 15 grams
Herba Violae 15 gram Herba Hedyotidis Diffusaes 25 gram Caulis Sargentodoxaes 25 grams.
Above-mentioned Chinese medicine through flushing with clean water, section and pulverizing, is put into extraction pot then, put into water at 1: 10, through 100 ℃ of steaming and decoctings 2 hours, filter, get and filter the back liquid cools and sealed in 24 hours by solid-to-liquid ratio.
Embodiment 4
Take by weighing raw material by following proportioning:
Wild Flos persicae 40 gram Radix Scutellariaes 40 gram Folium Isatidiss 40 gram Cortex Phellodendris 40 grams
Fructus Trichosanthis 22 gram Herba Taraxacis 40 gram Rhizoma Bistortaes the 40th grammes per square metre buildings 40 grams
Rhizoma Chuanxiong 22 gram Stigma Crocis 10 grams are hidden Ganoderma 40 gram Cordyceps 2 grams
Ramulus et folium taxi cuspidatae 40 gram Radix Et Rhizoma Rhei 22 gram Herba Patriniae 22 gram Cortex Moutans 22 grams
Herba Violae 22 gram Herba Hedyotidis Diffusaes 40 gram Caulis Sargentodoxaes 40 grams.
With above-mentioned Chinese medicine through flushing with clean water, section and pulverizing, put into extraction pot then, put into water at 1: 6 by solid-to-liquid ratio, through 100 ℃ of steaming and decoctings 1.5 hours, filtration, time filtrate of winning, extract once more, put into water at 1: 3 by solid-to-liquid ratio,, get filtrate for the second time through 100 ℃ of steaming and decoctings 0.5 hour, filtration, merge secondary filter liquid, cool off and sealed in 24 hours.
Embodiment 5
Liu Han east, Tai, Shandong, the grandfather of Liu Handong 95 years old suffer from stifled 7 days of intestinal stalk not defecation, hospital do not have what good method, it is just logical more than 1 day to take this medicine, just logical back decrement clothes 3 days.The father of Liu Handong more than 70 year old rectal cancer entirely more after, annual spring and autumn was respectively taken medicine 15 days until modern 8 years, health is very strong the same with the normal person.Wife's constipation bowel of Liu Handong stalk is stifled, does not have good method in the school of being in hospital of space flight hospital, and oral this medicine 1 day is just logical, just logical after decrement clothes 3 days again.
Embodiment 6
Medicine acute toxicity testing of the present invention:
Get 20 of mices, male and female half and half, body weight 16~23g, oral administration, drug decocting liquid of the present invention was condensed into 0.2ml/10g 1: 2,2 times/day, observed 7 days continuously none death of animal, and diet, activity, dorsal body setae, feces no abnormality seen all, put to death mice, the biopsy heart, liver, spleen, lung, kidney be no abnormality seen also, is limited to the reason of administration concentration, can't record LD 50, this medicine maximum tolerated dose is equivalent to 120 times of clinical consumption at least.
The pharmacodynamic experiment of medicine of the present invention
Be medicine of the present invention below to tumor-inhibiting action and to the experimental result of the influence of immune organ.
A. antihepatocarcinoma effect reaches the influence to immune organ
Get 50 of healthy kunming mouses, male and female half and half, body weight 14~18 grams are divided into 5 groups, the 1st, 2 group of injecting normal saline, the 3rd, 4 group of oral medicine of the present invention, the 5th group of subcutaneous injection fluorouracil injection at random.Oral dose: 0.2ml/10g, subcutaneous injection 0.1ml/10g, once a day.After the administration the 3rd day except that the 1st group of lumbar injection hepatoma carcinoma cell 0.2ml/ only (getting hepatic ascites is diluted to every ml with normal saline and contains oncocyte 2 * 10 6Individual) continued successive administration 10 days, take off cervical vertebra in the 11st day and put to death animal, take by weighing body weight respectively, go ascites body weight, spleen heavily to reach thymic weight, calculate tumor heavy (body weight subtracts the ascites body weight), spleen coefficient (the heavy mg/ body weight of spleen g), thymus coefficient (thymus mg/ body weight g), the results are shown in Table 1.
Table 1 medicine of the present invention is to the influence of liver cancer murine (X ± SD)
Figure A20091015838200091
Figure A20091015838200101
Relatively compare * P<0.01 with the normal control group in △ P<0.05 with the inoculation matched group
B. anti-sarcoma (S 180) effect and to the influence of immune organ
It is S that experimental technique removes inoculation tumor kind 180Outward, other are with experiment 1.The results are shown in Table 2.
Table 2 couple sarcoma S 180The influence of ascites (X ± SD)
Figure A20091015838200102
Relatively compare * P<0.05 with the normal control group in △ P<0.05 with the inoculation matched group
C. the influence of liver-cancer solid tumor
During experiment hepatocarcinoma tumor kind cell inoculation is being sat the forelimb abdominal part, animal grouping and administration experiment 1 are done contrast with fluorouracil and mitomycin respectively.Experimental result sees Table 3,4.Mitomycin group mouse death rate reaches 43.5% in the experimentation, and none death of medicine group of the present invention.
Table 3 medicine of the present invention is to the influence of liver-cancer solid tumor (X ± SD)
Compare △ P<0.05 with the normal saline group
Table 4 medicine of the present invention is to the influence of liver-cancer solid tumor (X ± SD)
Figure A20091015838200104
Compare △ P<0.01 * P<0.05 with the normal saline group
D. medicine of the present invention is to entity sarcoma S 180Influence
During experiment with tumor kind S 180Be seeded in and sit the forelimb abdominal part, other are with experiment 1.Experimental result sees Table 5.
Table 5 medicine of the present invention is to entity sarcoma S 180Influence (X ± SD)
Compare △ P<0.05 with the normal saline group.

Claims (10)

1, a kind of Chinese medicine composition for the treatment of intestinal tract disease is characterized in that it is the medicament of being made by the raw material of following weight portion:
Wild Flos persicae 25-45 Radix Scutellariae 25-45 Folium Isatidis 25-45
Cortex Phellodendri 25-45 Fructus Trichosanthis 15-35 Herba Taraxaci 35-55
Rhizoma Bistortae 25-45 Rhizoma Paridis 25-45 Rhizoma Chuanxiong 15-35
Stigma Croci 5-20 hides Ganoderma 25-45 Cordyceps 1-5
Ramulus et folium taxi cuspidatae 25-45 Radix Et Rhizoma Rhei 15-35 Herba Patriniae 15-35
Cortex Moutan 15-35 Herba Violae 15-35 Herba Hedyotidis Diffusae 25-45
Caulis Sargentodoxae 25-45.
2, the Chinese medicine composition of treatment intestinal tract disease according to claim 1 is characterized in that it is the medicament of being made by the raw material of following weight portion:
Wild Flos persicae 30-40 Radix Scutellariae 30-40 Folium Isatidis 30-40
Cortex Phellodendri 30-40 Fructus Trichosanthis 20-30 Herba Taraxaci 40-50
Rhizoma Bistortae 30-40 Rhizoma Paridis 30-40 Rhizoma Chuanxiong 20-30
Stigma Croci 10-20 hides Ganoderma 30-40 Cordyceps 2-4
Ramulus et folium taxi cuspidatae 30-40 Radix Et Rhizoma Rhei 20-30 Herba Patriniae 20-30
Cortex Moutan 20-30 Herba Violae 20-30 Herba Hedyotidis Diffusae 30-40
Caulis Sargentodoxae 30-40.
3, the Chinese medicine composition of treatment intestinal tract disease according to claim 1 is characterized in that it is the medicament of being made by the raw material of following weight portion:
Wild Flos persicae 30-35 Radix Scutellariae 30-35 Folium Isatidis 30-35
Cortex Phellodendri 30-35 Fructus Trichosanthis 25-30 Herba Taraxaci 45-50
Rhizoma Bistortae 30-35 Rhizoma Paridis 30-35 Rhizoma Chuanxiong 25-30
Stigma Croci 10-15 hides Ganoderma 30-35 Cordyceps 2-4
Ramulus et folium taxi cuspidatae 30-35 Radix Et Rhizoma Rhei 25-30 Herba Patriniae 25-30
Cortex Moutan 25-30 Herba Violae 25-30 Herba Hedyotidis Diffusae 30-35
Caulis Sargentodoxae 30-35.
4, the Chinese medicine composition of treatment intestinal tract disease according to claim 1 is characterized in that it is the medicament of being made by the raw material of following weight portion:
Wild Flos persicae 35 Radix Scutellariaes 35 Folium Isatidiss 35
Cortex Phellodendri 35 Fructus Trichosanthis 25 Herba Taraxacis 45
Rhizoma Bistortae 35 Rhizoma Paridis 35 Rhizoma Chuanxiongs 25
Stigma Croci 15 is hidden Ganoderma 35 Cordyceps 3
Ramulus et folium taxi cuspidatae 35 Radix Et Rhizoma Rhei 25 Herba Patriniae 25
Cortex Moutan 25 Herba Violaes 25 Herba Hedyotidis Diffusaes 35
Caulis Sargentodoxae 35.
5,, it is characterized in that described medicament is the above a dosage form of any pharmaceutics according to the Chinese medicine composition of the described treatment intestinal tract disease of one of claim 1-4.
6, the Chinese medicine composition of treatment intestinal tract disease according to claim 5 is characterized in that described dosage form is an oral liquid.
7, according to the preparation method of the Chinese medicine composition of the described treatment intestinal tract disease of one of claim 1-6, it is characterized in that above-mentioned Chinese medicine through flushing with clean water, section and pulverizing, put into extraction pot then, by solid-to-liquid ratio 1: 5-15 puts into water, through 100 ℃ of steaming and decocting 1.5-3 hours, filter, get and filter the back liquid cools and sealed in 24 hours.
8, the preparation method of the Chinese medicine composition of treatment intestinal tract disease according to claim 7, it is characterized in that above-mentioned Chinese medicine through flushing with clean water, section and pulverizing, put into extraction pot then, by solid-to-liquid ratio 1: 8-10 puts into water, through 100 ℃ of steaming and decocting 1.5-2 hours, filter, get and filter the back liquid cools and sealed in 24 hours.
9, the preparation method of the Chinese medicine composition of treatment intestinal tract disease according to claim 7, it is characterized in that just above-mentioned Chinese medicine through flushing with clean water, section and pulverizing, puts into extraction pot then, by solid-to-liquid ratio 1: 5-10 puts into water, through 100 ℃ of steaming and decocting 1.5-2 hours, filtration, win time filtrate extracts once more, and by solid-to-liquid ratio 1: 3-5 puts into water, through 100 ℃ of steaming and decocting 0.5-1 hours, filtration, filtrate for the second time, merge secondary filter liquid, cool off and sealed in 24 hours.
10,, it is characterized in that described intestinal tract disease is that enterodynia is swollen, the intestinal stalk is stifled, intestinal neoplasms and malignant tumor according to the application of the Chinese medicine composition of the described treatment intestinal tract disease of one of claim 1-4.
CN200910158382XA 2009-07-09 2009-07-09 Chinese medicinal composition for treating intestinal diseases and preparation method and application thereof Active CN101596267B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910158382XA CN101596267B (en) 2009-07-09 2009-07-09 Chinese medicinal composition for treating intestinal diseases and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910158382XA CN101596267B (en) 2009-07-09 2009-07-09 Chinese medicinal composition for treating intestinal diseases and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN101596267A true CN101596267A (en) 2009-12-09
CN101596267B CN101596267B (en) 2011-12-28

Family

ID=41417985

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910158382XA Active CN101596267B (en) 2009-07-09 2009-07-09 Chinese medicinal composition for treating intestinal diseases and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN101596267B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103721164A (en) * 2013-12-14 2014-04-16 郑明立 Medicine for treating intestinal obstruction and preparation method thereof
CN105963476A (en) * 2016-05-11 2016-09-28 张士舜 Traditional Chinese medicine composition for treating colorectal cancer and preparation method thereof
CN110734843A (en) * 2019-11-12 2020-01-31 晨光生物科技集团股份有限公司 fermentation system and fermentation method for simulating colon environment

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103721164A (en) * 2013-12-14 2014-04-16 郑明立 Medicine for treating intestinal obstruction and preparation method thereof
CN105963476A (en) * 2016-05-11 2016-09-28 张士舜 Traditional Chinese medicine composition for treating colorectal cancer and preparation method thereof
CN110734843A (en) * 2019-11-12 2020-01-31 晨光生物科技集团股份有限公司 fermentation system and fermentation method for simulating colon environment
CN110734843B (en) * 2019-11-12 2023-01-17 晨光生物科技集团股份有限公司 Fermentation system and fermentation method for simulating colon environment

Also Published As

Publication number Publication date
CN101596267B (en) 2011-12-28

Similar Documents

Publication Publication Date Title
CN102641423B (en) Chinese patent medicine composition for treating acute urticaria
CN102205107B (en) Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof
CN105343625A (en) Taraxacum oral liquid for expelling toxin, dehumidifying and benefiting gallbladder and preparation method thereof
CN102178800B (en) Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN103463297A (en) Traditional Chinese medicine composition for treating eczema of scrotum as well as preparation method and use thereof
CN101596267B (en) Chinese medicinal composition for treating intestinal diseases and preparation method and application thereof
CN100579562C (en) Oral Chinese medicine composition for treating constipation
CN102198203B (en) Traditional Chinese medicine for treating nonalcoholic fatty liver diseases
CN104288624A (en) Pharmaceutical composition and application thereof
CN103356932B (en) A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia
CN109692309A (en) Treat nonalcoholic fatty liver eliminating toxic dampness and heat side
CN105214032A (en) The solid dispersion tablet for the treatment of peptic ulcer
CN104784549A (en) Traditional Chinese medicine for treating allergic rhinitis
CN102416121B (en) Application of medicinal composition in preparation of medicaments for treating gastric ulcer
CN105250954B (en) A kind of Chinese medicine for treating IBS and preparation method thereof
CN103191399A (en) Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period
CN102641424B (en) Chinese prepared medicine mixture for treating acute urticaria
CN102416120B (en) Application of medicinal composition in preparation of medicament for treating erosive gastritis
CN102430073B (en) Medicinal composition for treating peptic ulcer
CN100394976C (en) Chinese medicine for withdrawal of drug dependence
CN104998140A (en) Traditional Chinese medicine preparation for treating chronic gastric ulcer
CN105214037A (en) The solid dispersal capsule for the treatment of peptic ulcer
CN105250946A (en) Solid dispersion for treating peptic ulcers
CN103877384A (en) Traditional Chinese medicine preparation for treating rectal cancer and preparation method thereof
CN102641422B (en) Chinese patent medicine for treating acute urticaria

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant